- Home
- EOG vs COR Comparison
EOG vs COR Comparison
Compare EOG & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EOG | COR |
|---|---|---|
| Founded | 1985 | 2001 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Other Pharmaceuticals |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.0B | 57.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | EOG | COR |
|---|---|---|
| Price | $105.70 | $340.25 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 24 | 13 |
| Target Price | $138.86 | ★ $360.62 |
| AVG Volume (30 Days) | ★ 3.7M | 1.2M |
| Earning Date | 02-26-2026 | 02-04-2026 |
| Dividend Yield | ★ 3.89% | 0.71% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | ★ 10.05 | 7.96 |
| Revenue | $22,654,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | N/A | $7.20 |
| Revenue Next Year | $7.83 | $6.62 |
| P/E Ratio | ★ $10.44 | $42.17 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $101.59 | $233.61 |
| 52 Week High | $138.18 | $377.54 |
Technical Indicators
Market Signals| Indicator | EOG | COR |
|---|---|---|
| Relative Strength Index (RSI) | 49.88 | 47.58 |
| Support Level | $102.42 | $333.79 |
| Resistance Level | $106.82 | $349.55 |
| Average True Range (ATR) | 2.20 | 6.10 |
| MACD | 0.20 | 0.02 |
| Stochastic Oscillator | 61.16 | 54.50 |
Price Performance
Historical ComparisonAbout EOG EOG Resources Inc.
EOG Resources is an oil and gas producer with acreage in several US shale plays, primarily in the Permian Basin and the Eagle Ford. At the end of 2024, it reported net proven reserves of 4.7 billion barrels of oil equivalent. Net production averaged roughly 1,062 thousand barrels of oil equivalent per day in 2024 at a ratio of 69% oil and natural gas liquids and 31% natural gas.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.